The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 7, 2026 | Hershberg Robert | Director | Option exercise(M) | 49K | $1.35 | $66K |
| Jul 7, 2026 | Hershberg Robert | Director | Option exercise(M) | 51K | $1.35 | $69K |
| Jul 7, 2026 | Hershberg Robert | Director | Sell(S) | 100K | $4.96 | $496K |
| Jul 7, 2026 | Hershberg Robert | Director | Option exercise(M) | 49K | — | $0 |
| Jul 7, 2026 | Hershberg Robert | Director | Option exercise(M) | 51K | — | $0 |
| Jun 26, 2026 | Kochendoerfer Gerd | Chief Operating Officer | Option exercise(M) | 50K | $1.60 | $80K |
| Jun 26, 2026 | Kochendoerfer Gerd | Chief Operating Officer | Sell(S) | 50K | $5.00 | $250K |
| Jun 26, 2026 | Kochendoerfer Gerd | Chief Operating Officer | Option exercise(M) | 50K | — | $0 |
| Jun 25, 2026 | Craig Kevin James | Chief Medical Officer | Option exercise(M) | 33K | $1.50 | $50K |
| Jun 25, 2026 | Craig Kevin James | Chief Medical Officer | Option exercise(M) | 10K | $1.18 | $11K |
| Jun 25, 2026 | Craig Kevin James | Chief Medical Officer | Sell(S) | 43K | $4.51 | $192K |
| Jun 25, 2026 | Craig Kevin James | Chief Medical Officer | Option exercise(M) | 33K | — | $0 |
| Jun 25, 2026 | Craig Kevin James | Chief Medical Officer | Option exercise(M) | 10K | — | $0 |
| Jun 4, 2026 | Angermayer Christian | Director, 10% Owner | Grant(A) | 122K | — | $0 |
| Jun 4, 2026 | Braunstein Scott | Director | Grant(A) | 122K | — | $0 |
| Jun 4, 2026 | Braunstein Scott | Director | Grant(A) | 86K | — | $0 |
| Jun 4, 2026 | Fischer Laurent | Director | Grant(A) | 122K | — | $0 |
| Jun 4, 2026 | Hershberg Robert | Director | Grant(A) | 122K | — | $0 |
| Jun 4, 2026 | Hoffman John Francis | Director | Grant(A) | 122K | — | $0 |
| Jun 4, 2026 | Kalali Amir H | Director | Grant(A) | 122K | — | $0 |
| Jun 4, 2026 | Smiley Andrea Heslin | Director | Grant(A) | 122K | — | $0 |
| Jun 4, 2026 | Johnson Sabrina Martucci | Director | Grant(A) | 122K | — | $0 |
| Apr 20, 2026 | Craig Kevin James | Chief Medical Officer | Option exercise(M) | 27K | $1.50 | $41K |
| Apr 20, 2026 | Craig Kevin James | Chief Medical Officer | Option exercise(M) | 15K | $1.84 | $28K |
| Apr 20, 2026 | Craig Kevin James | Chief Medical Officer | Sell(S) | 43K | $5.00 | $213K |
| Apr 20, 2026 | Craig Kevin James | Chief Medical Officer | Option exercise(M) | 27K | — | $0 |
| Apr 20, 2026 | Craig Kevin James | Chief Medical Officer | Option exercise(M) | 15K | — | $0 |
| Apr 8, 2026 | Angermayer Christian | Director, 10% Owner | Option exercise(M) | 46K | $1.88 | $87K |
| Apr 8, 2026 | Angermayer Christian | Director, 10% Owner | Option exercise(M) | 410K | $1.64 | $673K |
| Apr 8, 2026 | Angermayer Christian | Director, 10% Owner | Option exercise(M) | 103K | $1.34 | $138K |
| Apr 8, 2026 | Angermayer Christian | Director, 10% Owner | Option exercise(M) | 46K | — | $0 |
| Apr 8, 2026 | Angermayer Christian | Director, 10% Owner | Option exercise(M) | 410K | — | $0 |
| Apr 8, 2026 | Angermayer Christian | Director, 10% Owner | Option exercise(M) | 103K | — | $0 |
| Mar 20, 2026 | Craig Kevin James | Chief Medical Officer | Sell(S) | 100K | $3.55 | $355K |
| Mar 20, 2026 | Craig Kevin James | Chief Medical Officer | Option exercise(M) | 76K | $1.18 | $90K |
| Mar 20, 2026 | Craig Kevin James | Chief Medical Officer | Option exercise(M) | 24K | $1.50 | $36K |
| Mar 20, 2026 | Craig Kevin James | Chief Medical Officer | Option exercise(M) | 24K | — | $0 |
| Mar 20, 2026 | Craig Kevin James | Chief Medical Officer | Option exercise(M) | 76K | — | $0 |
| Mar 11, 2026 | Faerm Michael E. | Chief Financial Officer | Grant(A) | 1.3M | — | $0 |
| Mar 11, 2026 | Faerm Michael E. | Chief Financial Officer | Grant(A) | 285K | — | $0 |
| Jan 30, 2026 | Craig Kevin James | Chief Medical Officer | Grant(A) | 150K | — | $0 |
| Jan 30, 2026 | Craig Kevin James | Chief Medical Officer | Grant(A) | 675K | — | $0 |
| Jan 30, 2026 | Short Glenn Frank | Chief Scientific Officer | Grant(A) | 150K | — | $0 |
| Jan 30, 2026 | Short Glenn Frank | Chief Scientific Officer | Grant(A) | 675K | — | $0 |
| Jan 30, 2026 | Rao Srinivas | See remarks | Grant(A) | 2.0M | — | $0 |
| Jan 30, 2026 | Rao Srinivas | See remarks | Grant(A) | 442K | — | $0 |
| Jan 30, 2026 | Kochendoerfer Gerd | Chief Operating Officer | Grant(A) | 150K | — | $0 |
| Jan 30, 2026 | Kochendoerfer Gerd | Chief Operating Officer | Grant(A) | 675K | — | $0 |
| Jan 30, 2026 | Johnson Anne Nagengast | Chief Financial Officer | Grant(A) | 525K | — | $0 |
| Jan 30, 2026 | Johnson Anne Nagengast | Chief Financial Officer | Grant(A) | 117K | — | $0 |
| Jan 30, 2026 | Barrett Christopher Ryan Cave | See remarks | Grant(A) | 675K | — | $0 |
| Jan 30, 2026 | Barrett Christopher Ryan Cave | See remarks | Grant(A) | 150K | — | $0 |
| Jan 2, 2026 | Feilding-Mellen Cosmo | Director | Sell(S) | 40K | $3.90 | $154K |
| Nov 25, 2025 | Feilding-Mellen Cosmo | Director | Disposed to issuer(D) | 40K | — | $0 |
| Nov 25, 2025 | Feilding-Mellen Cosmo | Director | Grant(A) | 10K | — | $0 |
| Nov 5, 2025 | Feilding-Mellen Cosmo | Director | Grant(A) | 7.7M | — | — |
| Nov 5, 2025 | Feilding-Mellen Cosmo | Director | Grant(A) | 40K | — | $0 |
| Nov 5, 2025 | Feilding-Mellen Cosmo | Director | Grant(A) | 103K | — | $0 |
| Nov 5, 2025 | Hershberg Robert | Director | Grant(A) | 456K | — | $0 |
| Nov 5, 2025 | Hershberg Robert | Director | Grant(A) | 98K | — | $0 |
| Nov 5, 2025 | Hershberg Robert | Director | Grant(A) | 62K | — | $0 |
| Nov 5, 2025 | Hershberg Robert | Director | Grant(A) | 103K | — | $0 |
| Nov 4, 2025 | Braunstein Scott | Director | Grant(A) | 57K | — | $0 |
| Oct 1, 2025 | Barrett Christopher Ryan Cave | See Remarks | Grant(A) | 175K | — | $0 |
| Sep 30, 2025 | Apeiron Investment Group Ltd. | 10% Owner | Conversion(C) | 2.4M | — | — |
| Sep 30, 2025 | Apeiron Investment Group Ltd. | 10% Owner | Conversion(C) | 148K | — | — |
| Aug 14, 2025 | Apeiron Investment Group Ltd. | 10% Owner | Buy(P) | 8.7M | $2.19 | $19.0M |
| Aug 13, 2025 | Rao Srinivas | See Remarks | Grant(A) | 218K | — | $0 |
| Aug 13, 2025 | Rao Srinivas | See Remarks | Grant(A) | 651K | — | $0 |
| Jun 26, 2025 | Angermayer Christian | Director, 10% Owner | Grant(A) | 103K | — | $0 |
| Jun 26, 2025 | Braunstein Scott | Director | Grant(A) | 103K | — | $0 |
| Jun 26, 2025 | Fischer Laurent | Director | Grant(A) | 103K | — | $0 |
| Jun 26, 2025 | Hoffman John Francis | Director | Grant(A) | 206K | — | $0 |
| Jun 26, 2025 | Johnson Sabrina Martucci | Director | Grant(A) | 103K | — | $0 |
| Jun 26, 2025 | Kalali Amir H | Director | Grant(A) | 103K | — | $0 |
| Jun 26, 2025 | Smiley Andrea Heslin | Director | Grant(A) | 103K | — | $0 |
| Jun 2, 2025 | Angermayer Christian | Director, 10% Owner | Grant(A) | 132K | — | — |
| Mar 24, 2025 | Apeiron Investment Group Ltd. | 10% Owner | Buy(P) | 1.8M | $1.40 | $2.5M |
| Mar 21, 2025 | Short Glenn Frank | Chief Scientific Officer | Sell(S) | 13K | $1.35 | $18K |
| Mar 21, 2025 | Johnson Anne Nagengast | Chief Financial Officer | Sell(S) | 34K | $1.35 | $45K |
| Mar 21, 2025 | Rao Srinivas | See Remarks | Sell(S) | 75K | $1.35 | $102K |
| Mar 21, 2025 | Craig Kevin James | Chief Medical Officer | Sell(S) | 12K | $1.35 | $16K |
| Mar 21, 2025 | Kirpekar Sahil | Chief Business Officer | Sell(S) | 49K | $1.35 | $66K |
| Mar 14, 2025 | Johnson Anne Nagengast | Chief Financial Officer | Option exercise(M) | 100K | — | — |
| Mar 14, 2025 | Johnson Anne Nagengast | Chief Financial Officer | Option exercise(M) | 100K | — | $0 |
| Mar 14, 2025 | Kirpekar Sahil | Chief Business Officer | Option exercise(M) | 100K | — | — |
| Mar 14, 2025 | Kirpekar Sahil | Chief Business Officer | Option exercise(M) | 100K | — | — |
| Mar 14, 2025 | Rao Srinivas | See Remarks | Option exercise(M) | 175K | — | — |
| Mar 14, 2025 | Rao Srinivas | See Remarks | Option exercise(M) | 175K | — | $0 |
| Mar 14, 2025 | Short Glenn Frank | Chief Scientific Officer | Option exercise(M) | 33K | — | — |
| Mar 14, 2025 | Short Glenn Frank | Chief Scientific Officer | Option exercise(M) | 33K | — | $0 |
| Mar 14, 2025 | Craig Kevin James | Chief Medical Officer | Option exercise(M) | 20K | — | — |
| Mar 14, 2025 | Craig Kevin James | Chief Medical Officer | Option exercise(M) | 20K | — | $0 |
| Mar 3, 2025 | Johnson Anne Nagengast | Chief Financial Officer | Grant(A) | 758K | — | $0 |
| Mar 3, 2025 | Craig Kevin James | Chief Medical Officer | Grant(A) | 758K | — | $0 |
| Mar 3, 2025 | Short Glenn Frank | Chief Scientific Officer | Grant(A) | 758K | — | $0 |
| Feb 14, 2025 | Apeiron Investment Group Ltd. | 10% Owner | Buy(P) | 10.8M | $2.10 | $22.8M |
| Jan 7, 2025 | Rao Srinivas | See Remarks | Grant(A) | 2.3M | — | $0 |
| Jan 2, 2025 | Kochendoerfer Gerd | Chief Operating Officer | Grant(A) | 1.4M | — | $0 |
| Oct 4, 2024 | Brand Florian | See Remarks | Disposed to issuer(D) | 401K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-04-26 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).